EUCTR2010-021264-14-DE进行中（未招募）1 期
Vitamin K1 to slow vascular calcification in hemodialysis patients. Multicenter, multinational, randomized controlled clinical trial - VitaVasK
RWTH Aachen University represented by the rector, himself represented by the dean of the Medical Faculty0 个研究点目标入组 348 人开始时间: 2012年9月7日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 348
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Male or female = 18 years of age
- •- Not less than 6 months on hemodialysis
- •- Calcification score > 100
- •- Written consent to take part in the study
- •- Expectation of life not less than 18 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 114
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 234
排除标准
- •- Intake of Vitamin K
- •- History of thrombosis (except shunt occlusion)
- •- Intake of Vitamin K antagonists (e.g. Marcumar®)
- •- Inflammatory bowel disease
- •- tumor disease
- •- Short-bowel-syndrome
- •- Liver dysfunction
- •- anemia (Hb < 70 g/l)
- •- More than one stent in one coronary artery plus one or more stents in an additional artery
- •- Pulse > 100/min (resting heart rate)
- •- Women who are pregnant or breastfeeding
- •- Women without sufficient contraception
- •- Alcohol or drug abuse
- •- Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
- •- Subject unlikely to comply with protocol, e.g. uncooperative attitude, inability to return for follow-up-visits, and unlikelihood of completing the study
- •- Participation in a parallel clinical trial or participation in another clinical trial within the last 3 months
- •- Subjects who are in any state of dependency to the sponsor or the investigators
- •- Employees of the sponsor or the investigators
- •- Subjects who have been committed to an institution by legal or regulatory order
研究者
相似试验
撤回
3 期
Vitamin K1 to slow vascular calcification in hemodialysis patients (VitaVasK)vascular calcification1003843010014523NL-OMON40146RWTH Aachen80
进行中（未招募）
1 期
Vitamin K1 to slow vascular calcification in hemodialysis patientsMedDRA version: 19.1Level: LLTClassification code 10070496Term: Hemodialysis complicationSystem Organ Class: 100000004863MedDRA version: 19.1Level: LLTClassification code 10066622Term: Chronic hemodialysisSystem Organ Class: 100000004865MedDRA version: 19.1Level: PTClassification code 10051753Term: Vascular calcificationSystem Organ Class: 10047065 - Vascular disordersEUCTR2010-021264-14-BERWTH Aachen University348
终止
3 期
Vitamin K1 to Slow Progression of Vascular Calcification in HD PatientsCardiovascular DiseasesNCT01742273RWTH Aachen University63
Unknown
不适用
Vitamin K2 Effect on Vascular Stiffening in Subjects With a Poor Vitamin K-statusVascular StiffnessNCT02404519Maastricht University Medical Center240
已完成
1 期
Inhibition of coronary calcification by vitamin K2coronary calcificationJPRN-UMIN000002760Tokai University30